IRIS Institutional Research Information System - OPENBS Open Archive UniBS

LANZINI, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.970
EU - Europa 5.292
AS - Asia 3.864
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 17
AF - Africa 15
SA - Sud America 14
Totale 19.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.925
UA - Ucraina 2.296
CN - Cina 2.124
DE - Germania 806
SG - Singapore 657
HK - Hong Kong 537
FI - Finlandia 471
PL - Polonia 376
IT - Italia 367
IE - Irlanda 317
TR - Turchia 293
GB - Regno Unito 251
FR - Francia 208
IN - India 195
SE - Svezia 66
NL - Olanda 48
CA - Canada 43
EU - Europa 28
EE - Estonia 26
BE - Belgio 24
IR - Iran 16
VN - Vietnam 16
AU - Australia 13
MU - Mauritius 10
RO - Romania 9
RU - Federazione Russa 8
ID - Indonesia 7
CL - Cile 6
ES - Italia 4
JP - Giappone 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
BR - Brasile 3
HU - Ungheria 3
AL - Albania 2
BD - Bangladesh 2
CO - Colombia 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
ET - Etiopia 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
EG - Egitto 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
SA - Arabia Saudita 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 19.200
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.555
Fairfield 1.120
Woodbridge 850
Ann Arbor 668
Chandler 648
Princeton 624
Nanjing 563
Ashburn 540
Hong Kong 536
Houston 506
Cambridge 500
Singapore 499
Wilmington 480
Seattle 397
Warsaw 374
Dublin 316
Istanbul 257
Dearborn 247
Nanchang 229
Beijing 222
New York 206
Helsinki 163
Des Moines 148
Shenyang 148
Hebei 136
Changsha 119
Tianjin 94
Jinan 89
San Diego 88
Milan 86
Jiaxing 80
Shanghai 72
Kunming 58
Verona 52
Hangzhou 50
Lancaster 49
Groningen 44
San Mateo 42
Ningbo 36
Haikou 33
Brescia 32
Los Angeles 32
Kocaeli 29
Lanzhou 29
Augusta 27
Tallinn 24
Monmouth Junction 23
Ottawa 23
Brussels 22
San Francisco 22
Changchun 21
Zhengzhou 20
Springfield 19
Taizhou 19
Norwalk 18
Guangzhou 16
Leawood 16
Toronto 15
Ardabil 14
Romola 14
Taiyuan 14
Hefei 13
Montichiari 13
Boardman 12
Dong Ket 12
London 11
Mumbai 10
Auburn Hills 9
Fuzhou 9
Redwood City 9
Orange 8
Munich 7
Phoenix 7
Canberra 6
Chiswick 6
Frankfurt am Main 6
Redmond 6
Stuttgart 6
Bergamo 5
Jakarta 5
Napoli 5
Pune 5
Sydney 5
Timisoara 5
Chisinau 4
New Delhi 4
Palermo 4
Providence 4
Rome 4
Chengdu 3
Gunzenhausen 3
Indiana 3
Kilburn 3
Kuopio 3
Lappeenranta 3
Las Vegas 3
Santa Clara 3
Amsterdam 2
Bangkok 2
Baotou 2
Totale 13.603
Salva come PNG Salva come JPEG
Nome #
Abnormal anandamide metabolism in celiac disease 291
Addicts with chronic hepatitis C: Difficult to reach, manage or treat? 247
Persistent intraepithelial lymphocytosis in celiac patients adhering to gluten-free diet is not abolished despite a gluten contamination elimination diet 246
Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet 209
Anti-TCR gamma antibody in celiac disease: the value of count on formalin-fixed paraffin-embedded biopsies. 132
Factors that contribute to hypertransaminasemia in patients with celiac disease or functional gastrointestinal syndromes 129
Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients. 125
Five year time course of celiac disease serology during gluten free diet: results of a community based " CD-Watch" program. 124
Effetto della somministrazione protratta di acido ursocolico sulla composizione lipidica biliare e sulla dissoluzione dei calcoli in pazienti colelitiasici. SOCIETA' ITALIANA DI GASTROENTEROLOGIA - CONGRESSO NAZIONALE - MILANO 14-16 NOVEMBRE - 120
Randomised clinical study: Gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non-coeliac gluten sensitivity 117
Gastrointestinal Pathologic Abnormalities in Pediatric- and Adult-Onset Common Variable Immunodeficiency 114
Triticum monococcum in patients with celiac disease: a phase II open study on safety of prolonged daily administration 109
New cephalosporins in the treatment of urinary tract infections and respiratory tract infections in hospitalised patients: clinical review. 107
Gallbladder motor function in man 106
A new concept of gallbladder (GB) motor function in man. 106
Editorial: Noncoeliac gluten sensitivity - The controversy rages on. Authors' reply 106
High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease 105
Neuroautonomic function is impaired in celiac patients. 105
A new method for quantitative measurement of gallbladder filling and emptying during fasting and eating. 104
Celiac disease with mild enteropathy is not mild disease 104
Letter: Gluten challenge in the era of noncoeliac gluten sensitivity - A change in clinical practice? Author's reply 104
Liver: Enterohepatic circulation 102
Gallbladder motor function in man 101
Review article: bile acid therapy 101
POST-INFECTIOUS IRRITABLE BOWEL SYNDROME FOLLOWING A WATER BORNE nOROVIRUS-eNTEROVIRUS GASTROENTERITIS OUTBREAK. 99
Elevation of serum gamma-glutamyltranspeptidase activity is frequent in chronic hepatitis C, and is associated with insulin resistance. 98
A new concept of gallbladder (GB) motor function in man. 98
A new method for measurement of biliary pharmacokinetics under physiological conditions in man. 97
A new concept of gallbladder (GB) motor function in man. 95
Clinical expression of lymphocytic duodenosis in "mild enteropathy" celiac disease and in functional gastrointestinal syndromes 95
A Survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon 94
Absence of Helicobacter pylori in dental plaque determined by immunoperoxidase 94
Neuropsychological pattern during gluten free diet (GFD) in elderly coeliac patients. 94
Management of recurrent gallstones 93
Repeated bile acid therapy for long-term management of cholesterol gallstones 93
The multidisciplinary team for management of inflammatory bowel diseases 93
Epidemiological, clinical and histopathologic characteristics of celiac disease: results of a case-finding population-based program in an Italian community. 92
Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. 92
Quantification of temocillin biliary excretion and gallbladder bile concentration in healthy subjects. 91
Maintenance of hepatic bile acid secretion rate during overnight fasting by bedtime bile acid administration 91
Simultaneous quantitative measurements of absolute gallbladder storage and emptying during fasting and eating in humans 91
Clinical trial: five or ten cycles of granulocyte-monocyte apheresis show equivalent efficacy and safety in ulcerative colitis. 91
Quantitative measurement of biliary excretion and of gallbladder concentration of drugs under physiological conditions in man. 90
Five year time course of celiac disease serology during gluten free diet: Results of a community based " CD-Watch" program 90
Effect of chronic ursocholic acid administration on bile lipid composition and bile acid pool size in gallstone patients 88
Exhaled nitric oxide as a marker of lung involvement in Crohns disease. 88
Hepatic biliary lipid secretion and gallbladder biliary lipid mass in gallstone patients: effect of ursodeoxycholic acid. 86
Postprandial biliary and pancreatic secretion during profound inhibition of gastric secretion in humans 86
Cognitive impairment during gluten free diet (GFD) in elderly coeliac patients. 85
Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives 84
Intestinal absorption of the bile acid analogue 75Se-Homocholic-acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. 84
Management of recurrent gallstones 83
Effect of long-term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans 82
Enterohepatic circulation 82
Gastroesophageal reflux disease and Barrett's esophagus. 82
Neuroautonomic function is impaired in celiac patients. 82
Regional differences of mucosal hydrophobicity in the gastrointestinal tract of healthy subjects 82
Small intestinal transit of a solid meal in gallstone patients and in healthy controls. 82
Retrospective, observational, multicentre study on an italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study. 81
Effect of chronic ursocholic acid administration to gallstone patients. IX INTERNATIONAL BILE ACID MEETING - BASEL - OCTOBER - 19-21 80
Helicobacter pylori infection in patients with celiac disease 80
Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. 80
Therapeutic manipulation of the enterohepatic circulation cholesterol cholelithiasis. 80
Retention of a bile acid analogue in the enterohepatic circulation (EHC) in primary biliary cirrhosis (PBC): comparison with normal controls and effect of bile acid treatment. 80
Bile acid binding to dietary protein. 80
Effect of ursodeoxycholic acid on biliary lipid coupling and on cholesterol absorption during fasting and eating in subjects with cholesterol gallstones 79
Best-buy regimen of ursodeoxycholic acid for patients with gallstones 79
Bile acid binding to dietary protein 79
Biliary pharmacokinetics under physiological conditions in man: validation of a new method. IX INTERNATIONAL BILE ACID MEETING - BASEL - OCTOBER - 19-21 78
Optimum bile acid treatment for rapid gallstone dissolution 78
Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet 78
Biliary pharmacokinetics and gallblader bile concentration of cefotan in healty volunteers.14th INTERNATIONAL CONGRESS OF CHEMOTHERAPY - JUNE - 23-28 - KYOTO - 77
Digestive endoscopy and portal hypertension 76
Four years time course of celiac disease (CD) serology during gluten free diet (GFD) resluts of a community based program. 76
Incidence of post-infectious irritable bowel sydrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak 76
Effect of chronic ursocholic acid administration on bile acid pool size and composition in man. 76
Potential celiac disease is not a mild disease: a single unit study in a color of 1140 patients 75
Efficacy and tolerability of combination therapy with interferon-alfa plus ribavirin in patients with chronic hepatitis C virus infection: a single-center study in relapsers and nonresponders to previous treatment with high-dose interferon-alfa monotherapy 74
HLA gene dose effect and helicobacter pylori infection do not contribute to persistence od intraepithelial lymphocitosis frequently observed in celiac patients adherent to gluten free diet. 73
Effect of ursodeoxycholic acid (UDCA) on pancreatic enzyme secretion and gallbladder (GB) emptying. 73
A phase II, single blind, cross-over study of acute administration of Triticun Monococcun (Cultivar Monlis) in patitents with celiac disease (CD). 72
Are cardiovascular rik factors affected by gluten free diet in celiac patients? Results in a cohor of 765 patients. 72
75-SeHCAT retention test in chronic cholestatic disease: comparison with health and effect of bile acid therapy. 72
Tissue transglutaminases antibodies (T-TGA) level as predictor of villous atrophy among adult unselected patients twith sispected celiac disease (CD 72
Biliary excretory kinetics of cefoetan in health.Vth MEDITERANEAN CONGRESS OF CHEMOTHERAPY - CAIRO - 26 OCTOBER - 1 NOVEMBER - 71
Effect of chronic administration of tauro-hyodeoxycholic acid on biliary bile acid composition and on biliary lipid secretion in humans 71
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial. 71
Persistence of intraepithelial lymphocytosis in celiac patietns adherent to gluten free diet: is there a HLA gene dose effec or a role for Helicobacter pylori infection ? 71
Coeliac disease: a histological follow-up study. 70
Is severity of duodenal histopatology morrored by differences in clinical and laboratory presentation in celiac disease ? A single unit study in a cohort of 1140 patients. 70
Dental plaque as a reservoir for helicobacter pylori (HP): does immunochemistry answer the question ? 70
Biliary excretory kinetics of cefotetan in healthy volunteers. 69
Extraintestinal manifestations in Crohn's disease: risk factors and influence of intestinal surgery. 69
CARDIOVASCULAR RISK FACTORS ARE AFFECTED BY GLUTEN FREE DIET (GFD) IN CELIAC DISEASE (CD): RESULTS IN A COHORT OF 765 PATIENTS. 69
HLA gene dose effect does not contribute to persistence of intraepithelial lymphocytosis frequently observed in celiac patientis adherent to gluten free diet. 69
Authors' replay: Comment to "High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease" 69
Silent celiac disease is frequent in the siblings of newly diagnosed celiac patients. 68
Celiac dsease at the time of dianosis: age-relted differences in clinical, serological and histopathological features 68
Is villous atrophy predictable by high tissue-transglutaminases antibodies (T-Tga) level in unselected adult patients evaluated for celiac disease (CD) ? 68
Postinfectious functional intestinal disorders following a waterborn norovirus gastroenteritis our break 68
Totale 9.368
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.678
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.387 0 0 0 0 192 654 449 572 234 755 165 366
2020/20213.460 39 419 34 413 49 434 83 517 665 230 501 76
2021/20222.162 84 445 33 202 12 80 53 193 96 298 217 449
2022/20231.845 339 49 13 146 149 581 4 189 241 6 68 60
2023/20241.649 106 31 80 121 71 253 47 36 545 18 27 314
2024/20251.088 17 26 20 532 493 0 0 0 0 0 0 0
Totale 19.549